ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,631.22
      0.28%
      US Tech 100
      19,850.00
      0.02%
      Dow Jones
      40,211.72
      0.53%
      Brent Oil
      83.63
      -0.84%
      Bitcoin
      63,139.79
      -2.64%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Passage Bio Inc (PASG)

      7. Passage Bio Inc (PASG) News

      PASG

      Passage Bio (PASG)

      Passage Bio Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:PASG
      DateTimeSourceHeadlineSymbolCompany
      03/03/20217:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PASGPassage Bio Inc
      03/03/20217:00AMGlobeNewswire Inc.Passage Bio Reports Fourth Quarter and Full-Year 2020 Financial Results and Recent Business HighlightsNASDAQ:PASGPassage Bio Inc
      03/02/20214:01PMGlobeNewswire Inc.Passage Bio to Participate in Upcoming March Investor ConferencesNASDAQ:PASGPassage Bio Inc
      02/24/20217:00AMGlobeNewswire Inc.Passage Bio to Report Fourth Quarter and Full-Year 2020 Financial Results on March 3, 2021NASDAQ:PASGPassage Bio Inc
      02/22/20215:43PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PASGPassage Bio Inc
      02/19/20215:02PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PASGPassage Bio Inc
      02/19/20217:00AMGlobeNewswire Inc.Passage Bio Appoints Maxine Gowen, Ph.D. to Board of DirectorsNASDAQ:PASGPassage Bio Inc
      02/12/20214:44PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PASGPassage Bio Inc
      02/11/20215:07PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PASGPassage Bio Inc
      02/08/202110:31AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PASGPassage Bio Inc
      02/08/20217:00AMGlobeNewswire Inc.FDA Clears IND Application for Passage Bio’s Gene Therapy Candidate PBKR03 for Treatment of Patients with Early Infantile K...NASDAQ:PASGPassage Bio Inc
      01/28/20211:48PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PASGPassage Bio Inc
      01/28/20217:00AMGlobeNewswire Inc.Passage Bio Receives FDA Clearance of IND Application for PBFT02 Gene Therapy Candidate for Treatment of Patients with Fronto...NASDAQ:PASGPassage Bio Inc
      01/22/20215:54PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PASGPassage Bio Inc
      01/21/20217:48PMGlobeNewswire Inc.Passage Bio Announces Pricing of Public OfferingNASDAQ:PASGPassage Bio Inc
      01/19/20214:05PMGlobeNewswire Inc.Passage Bio Announces Launch of Proposed Public OfferingNASDAQ:PASGPassage Bio Inc
      01/19/20214:04PMEdgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:PASGPassage Bio Inc
      01/19/20217:00AMGlobeNewswire Inc.Passage Bio to Host First of a Series of 2021 Virtual R&D Events on January 25NASDAQ:PASGPassage Bio Inc
      01/11/20217:15AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PASGPassage Bio Inc
      01/11/20217:00AMGlobeNewswire Inc.Passage Bio Announces Plan to Deliver on Multiple Meaningful Catalysts in 2021NASDAQ:PASGPassage Bio Inc
      01/04/20214:01PMGlobeNewswire Inc.Passage Bio to Present at the 39th Annual J.P. Morgan Healthcare ConferenceNASDAQ:PASGPassage Bio Inc
      01/04/20217:00AMGlobeNewswire Inc.Passage Bio Receives FDA Clearance of IND Application for Lead Gene Therapy Candidate PBGM01 for Treatment of Infantile GM1 G...NASDAQ:PASGPassage Bio Inc
      12/18/20207:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PASGPassage Bio Inc
      12/16/20208:00AMGlobeNewswire Inc.Passage Bio Announces Gene Therapy Manufacturing Research and Development SiteNASDAQ:PASGPassage Bio Inc
      12/10/20204:01PMGlobeNewswire Inc.Passage Bio Receives MHRA Clinical Trial Authorization for PBGM01 for Treatment of GM1 GangliosidosisNASDAQ:PASGPassage Bio Inc
      12/07/20207:00AMGlobeNewswire Inc.Passage Bio Teams with Catalent to Start CGMP Manufacturing for Lead Gene Therapy ProductsNASDAQ:PASGPassage Bio Inc
      11/23/20204:01PMGlobeNewswire Inc.Passage Bio to Present at Piper Sandler 32nd Annual Healthcare ConferenceNASDAQ:PASGPassage Bio Inc
      11/11/20204:30PMGlobeNewswire Inc.Passage Bio Highlights University of Pennsylvania’s Gene Therapy Program’s Newly Published Research to Prevent Toxicity A...NASDAQ:PASGPassage Bio Inc
      11/11/20207:00AMGlobeNewswire Inc.Passage Bio to Participate in Upcoming November Investor ConferencesNASDAQ:PASGPassage Bio Inc
      11/10/20208:01AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PASGPassage Bio Inc
       Showing the most relevant articles for your search:NASDAQ:PASG

      Your Recent History

      LSE
      UC14
      Ubsetf Ccusas
      Delayed Upgrade Clock